Trials / Completed
CompletedNCT00559546
Montelukast as a Controller of Atopic Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- University of Helsinki · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to find out if montelukast can be used to treat the various symptoms of allergic syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast | 10 mg montelukast tablet each evening for 3 weeks or placebo for 3 weeks in cross-over manner |
Timeline
- Start date
- 2007-03-01
- Completion
- 2007-07-01
- First posted
- 2007-11-16
- Last updated
- 2007-11-16
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00559546. Inclusion in this directory is not an endorsement.